CYP2C8 and breast cancer: Breast Cancer Patients carrying CYP2C8*3 haplotype are associated with increased risk of neurotoxicity. Polymorphism T274M in Beta Tubulin VI (BTT VI) gene is associated with severe myelosuppression in patient treated to Taxanes